NCT00081302View on ClinicalTrials.gov

Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

November 30, 2013

Conditions

Lung Cancer

Interventions

BIOLOGICAL

cetuximab

DRUG

carboplatin

DRUG

paclitaxel

RADIATION

radiation therapy

Trial Locations (1)

76012

Arlington Cancer Center - Arlington, Arlington

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Radiation Therapy Oncology Group

NETWORK

NCT00081302 - Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter